← Back to Search

Case Control for COVID-19 ((EPOC) Trial)

N/A
Waitlist Available
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years.
Informed consent by the patient or the patient's legally authorized representative (LAR) for up to 4 fingersticks for POC testing and a blood draw for stored blood samples.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month following intervention
Awards & highlights

(EPOC) Trial Summary

This trial will compare the accuracy of two different at-home coronavirus tests.

Eligible Conditions
  • COVID-19
  • Coronavirus

(EPOC) Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

(EPOC) Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month following intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month following intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The frequency with which the POC test fails to give an unambiguous result.

(EPOC) Trial Design

1Treatment groups
Experimental Treatment
Group I: COVID19 AssaysExperimental Treatment3 Interventions
All participants enrolled will receive 2 point of care assays, and 1 central lab assay
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LumiraDX
2022
N/A
~330
RightSign
2022
N/A
~330
Case Control
2022
N/A
~330

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,367 Previous Clinical Trials
1,587,179 Total Patients Enrolled
26 Trials studying COVID-19
26,615 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~113 spots leftby Mar 2025